Laboratory workers who frequently handle Neisseria meningitidis are strongly recommended to receive MenACWY and MenB vaccines
Laboratory workers who are at occupational risk of exposure to Neisseria meningitidis are strongly recommended to receive vaccines against all vaccine-preventable meningococcal serogroups. Specifically:
- 1 dose of MenACWY vaccine
- 2 doses of MenB vaccine
For MenACWY vaccine, it is preferable for laboratory workers to receive either Menveo or Nimenrix, rather than Menactra. If Menveo and Nimenrix are unavailable, Menactra can be given.
There is no preference for either brand of MenB vaccine — Bexsero or Trumenba — for laboratory workers.
Bexsero and Trumenba are not interchangeable. The same vaccine should be used for both vaccine doses.
People with ongoing occupational exposure risks are recommended to receive a MenACWY booster dose every 5 years.
People who have previously received a meningococcal polysaccharide vaccine
Laboratory workers with ongoing occupational exposure risks who have previously received a quadrivalent meningococcal polysaccharide vaccine (4vMenPV) are recommended to receive 1 dose of MenACWY conjugate vaccine. They should receive this dose about 2 years after the most recent dose of 4vMenPV, with a recommended minimum interval of 6 months.1-3 They are also recommended to receive booster doses of MenACWY vaccine (see Booster doses).
- quadrivalent meningococcal polysaccharide vaccine
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/laboratory-workers-who-frequently-handle-neisseria-meningitidis-are-strongly.